Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker-Reference-Cited by-同舟云学术

Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker

Published:2012-08-26 Issue:1 Volume:15 Page:71-76
ISSN:1532-2092
Container-title:EP Europace
language:en
Short-container-title:

Author:

Schuchert Andreas¹,Muto Carmine²,Maounis Themistoklis³,Frank Robert⁴,Boulogne Eric⁵,Polauck Alexander⁶,Padeletti Luigi⁷,

Affiliation:

1. Friedrich-Ebert Hospital, Medical Clinic, Friesenstr. 11, D 24531 Neumünster, Germany

2. Ospedale Loreto Mare, Naples, Italy

3. Onassis Cardiac Center, Athens, Greece

4. Hopital Pitie-Salpetriere, Paris, France

5. St Jude Medical, Zaventem, Belgium

6. St Jude Medical, Eschborn, Germany

7. Department of Heart and Vessel, University of Florence Cliniche Gavazzeni, Bergamo, Italy

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/15/1/71/17858835/eus247.pdf

Reference21 articles.

1. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association;Dickstein;Europace,2010

2. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure;Lindenfeld;Circulation,2007

3. Cardiac resynchronization pacing without deﬁbrillator capability: is this a viable option?;Ermis;Europace,2006

4. Cardiac resynchronization therapy: which device to implant?;Leclercq;Arch Cardiovasc Dis,2008

5. Cardiac resynchronization therapy in combination with implantable cardioverter-deﬁbrillator;Daubert;Europace,2009

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure, sudden cardiac death and implantable cardioverter-defibrillators: sex matters;Journal of Cardiovascular Medicine;2024-08-13

2. Understanding the Application of Mechanical Dyssynchrony in Patients with Heart Failure Considered for CRT;Journal of Cardiovascular Development and Disease;2024-02-17

3. When Is Cardiac Resynchronization Therapy with a Defibrillator Indicated in Patients with Heart Failure, Especially Elderly Patients?;International Heart Journal;2023-05-31

4. Complications in Device Therapy: Spectrum, Prevalence, and Management;Current Heart Failure Reports;2022-08-06

5. How We Indicate Implantable Cardioverter–Defibrillator for Heart Failure Patients, Especially in Elderly Patients?;SSRN Electronic Journal;2022